Market cap data unavailable. We couldn't positively verify this ticker's market cap is under $500M. Verify independently before trading.
Hestia Insight Inc. delivers specialized strategic consulting and capital market advisory support, primarily catering to small to mid-sized businesses within the healthcare, biotech, and fintech sectors. The company's service portfolio also extends to healthcare management and patient-focused solutions. Moreover, Hestia Insight Inc. is involved in creating and analyzing healthcare technologies, specifically those related to neurological and psychiatric conditions. Completing its range of services, the firm provides management and assistance for medical supply sales, alongside comprehensive sales and marketing strategy and guidance. Formerly known as Luxshmi Investments, Inc., the company officially rebranded to Hestia Insight Inc. in May 2019. It operates from its headquarters in Las Vegas, Nevada.
Hestia Insight and Escher AI Enter Strategic Partnership to Develop Enterprise AI Tools for Capital Markets
Hestia Insight formed a strategic partnership with Escher AI to develop enterprise AI tools for corporate compliance, capital markets media, and company communications.
The initial phase targets three specific tools: AI-assisted compliance software, media production tools, and a marketing agent, integrating technologies like autonomous agents and advanced LLMs.
Hestia will oversee corporate compliance and distribution while Escher AI handles engineering and deployment, extending Hestia's existing Impact-O platform.